The effect of dipeptidyl peptidase-IV inhibition on the immune functions in patients with type 2 diabetes

被引：0
|
作者：
Sromova, L. [1 ]
Busek, P. [1 ]
Mareckova, H. [2 ]
Potockova, J. [3 ,4 ]
Andel, M. [3 ,4 ]
Sedo, A. [1 ]
机构：
[1] Inst Biochemsitry & Expt Oncol, Canc Cell Biol Lab, Prague, Czech Republic
[2] Charles Univ Prague, Inst Immunol & Microbiol, Fac Med 1, Prague, Czech Republic
[3] Charles Univ Prague, Dept Internal Med 2, Fac Med 3, Prague, Czech Republic
[4] Fac Hosp Kralovske Vinohrady, Prague, Czech Republic
来源：
FEBS JOURNAL | 2014年 / 281卷
关键词：
dipeptidyl peptidase; immune regulation; sitagliptin;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
SUN-318
引用
收藏
页码：173 / 173
页数：1
相关论文
共 50 条
  • [1] The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes
    Gallagher, Emily Jane
    Sun, Hui
    Kornhauser, Caroline
    Tobin-Hess, Aviva
    Epstein, Sol
    Yakar, Shoshana
    LeRoith, Derek
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 (03) : 191 - 200
  • [2] The effect of dipeptidyl peptidase-IV inhibition on circulating T cell subpopulations in patients with type 2 diabetes mellitus
    Sromova, Lucie
    Busek, Petr
    Posova, Helena
    Potockova, Jana
    Skrha, Pavel
    Andel, Michal
    Sedo, Aleksi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 118 : 183 - 192
  • [3] Dipeptidyl peptidase-IV inhibitors: fixing type 2 diabetes?
    McIntyre, Hugh F.
    Grant, Paul
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2007, 68 (11) : 599 - 602
  • [4] Alogliptin - A dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes
    Glode, Ashley
    Abdelghany, Sam
    FORMULARY, 2008, 43 (09) : 317 - +
  • [5] Vildagliptin - A dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes
    Schlesselman, Lauren S.
    FORMULARY, 2006, 41 (10) : 494 - +
  • [6] INHIBITION OF FIBRIN POLYMERIZATION BY DIPEPTIDYL PEPTIDASE-IV
    MENTLEIN, R
    HEYMANN, E
    HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1982, 363 (09): : 984 - 984
  • [7] Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin
    Taldone, Tony
    Zito, S. William
    Talele, Tanaji T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (02) : 479 - 484
  • [8] Alogliptin, a potent and selective dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes
    Deacon, Carolyn F.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (04) : 402 - 413
  • [9] Therapeutic potential of dipeptidyl peptidase-IV inhibitors in patients with diabetes mellitus
    Moore, Kevin B.
    Saudek, Christopher D.
    AMERICAN JOURNAL OF THERAPEUTICS, 2008, 15 (05) : 484 - 491
  • [10] Inhibition of the activity of dipeptidyl peptidase IV as a treatment for type 2 diabetes
    Holst, JJ
    Deacon, CF
    DIABETES, 1998, 47 (11) : 1663 - 1670
12345